These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 36612628)
1. Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer. Hsieh CY; Lin CY; Wang SS; Chou YE; Chien MH; Wen YC; Hsieh MJ; Yang SF Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612628 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer. Su CW; Huang YW; Chen MK; Su SC; Yang SF; Lin CW Medicine (Baltimore); 2015 Nov; 94(46):e2092. PubMed ID: 26579821 [TBL] [Abstract][Full Text] [Related]
3. Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan. Chung JF; Chen CL; Nassef Y; Shiu BH; Wang CH; Kuo FH; Hsiao YH; Yang SF; Wang PH Int J Med Sci; 2022; 19(6):1013-1022. PubMed ID: 35813301 [TBL] [Abstract][Full Text] [Related]
4. Associations of Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605 [TBL] [Abstract][Full Text] [Related]
5. TIMP3 Gene Polymorphisms of -1296 T > C and -915 A > G Increase the Susceptibility to Arsenic-Induced Skin Cancer: A Cohort Study and In Silico Analysis of Mutation Impacts. Wu MM; Chen CW; Chen CY; Lee CH; Chou M; Hsu LI; Lee TC; Chen CJ Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499314 [TBL] [Abstract][Full Text] [Related]
6. Association of the interaction between the rs9619311 and rs402007 polymorphisms and smoking with essential hypertension in Chinese Han population. Chen C; Yang M; Dou LP; Ling DM; Huang S Medicine (Baltimore); 2020 Jun; 99(23):e20552. PubMed ID: 32502021 [TBL] [Abstract][Full Text] [Related]
7. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study. Banday MZ; Sameer AS Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064 [No Abstract] [Full Text] [Related]
8. Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer. Hsieh CY; Chou YE; Lin CY; Wang SS; Chien MH; Tang CH; Lin JC; Wen YC; Yang SF Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33228130 [TBL] [Abstract][Full Text] [Related]
9. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort. Srivastava P; Kapoor R; Mittal RD Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201 [TBL] [Abstract][Full Text] [Related]
10. The impact of receptor of advanced glycation end-products polymorphisms on prostate cancer progression and clinicopathological characteristics. Chou YE; Hsieh MJ; Wang SS; Lin CY; Chen YY; Ho YC; Yang SF J Cell Mol Med; 2021 Nov; 25(22):10761-10769. PubMed ID: 34708514 [TBL] [Abstract][Full Text] [Related]
11. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer. Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574 [TBL] [Abstract][Full Text] [Related]
12. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. Freedland SJ; Csathy GS; Dorey F; Aronson WJ J Urol; 2002 Feb; 167(2 Pt 1):516-20. PubMed ID: 11792909 [TBL] [Abstract][Full Text] [Related]
13. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease]. Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638 [TBL] [Abstract][Full Text] [Related]
14. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma. Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358 [TBL] [Abstract][Full Text] [Related]
15. Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma. Weng WC; Hsieh MH; Chiou HL; Lee CY; Tang CH; Chang LC; Wang SS; Yang SF J Cancer; 2023; 14(3):360-366. PubMed ID: 36860920 [TBL] [Abstract][Full Text] [Related]
16. TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women. Tsai HT; Hsieh MJ; Chiou HL; Lee HL; Hsin MC; Liou YS; Yang CC; Yang SF; Kuo WH Tumour Biol; 2014 Sep; 35(9):8999-9007. PubMed ID: 24903383 [TBL] [Abstract][Full Text] [Related]
17. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Freedland SJ; Aronson WJ; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Terris MK; Urology; 2003 Apr; 61(4):742-7. PubMed ID: 12670558 [TBL] [Abstract][Full Text] [Related]
18. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease. Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345 [TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility. Wieczorek E; Reszka E; Jablonowski Z; Jablonska E; Krol MB; Grzegorczyk A; Gromadzinska J; Sosnowski M; Wasowicz W BJU Int; 2013 Dec; 112(8):1207-14. PubMed ID: 23819551 [TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]